Antiviral treatment in patients with cytomegalovirus positive ulcerative colitis

doi:10.4291/wjgp.v5.i4.589

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4476)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

226

WORD

161

HTML

1669

Tables (1-1)

223

Sum=2279

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1001

Download

1196

Sum=2197

Nov 15, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letters To The Editor

World J Gastrointest Pathophysiol. Nov 15, 2014; 5(4): 589-590
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.589

Antiviral treatment in patients with cytomegalovirus positive ulcerative colitis

Kadir Ozturk

Kadir Ozturk, Department of Gastroenterology, Gulhane School of Medicine, GATA Gastroenteroloji BD, Etlik, 06010 Ankara, Turkey

Author contributions: Ozturk K contributed to the paper.

Correspondence to: Kadir Ozturk, MD, PhD, Department of Gastroenterology, Gulhane School of Medicine, GATA Gastroenteroloji BD, General Tevfik Saglam Street, Etlik, 06010 Ankara, Turkey. kadirozturk3041@gmail.com

Telephone: +90-312-3044047 Fax: +90-312-3044045

Received: May 6, 2014
Revised: June 29, 2014
Accepted: September 16, 2014
Published online: November 15, 2014

Core Tip

Core tip: Many studies suggested that cytomegalovirus (CMV) infection is an exacerbating factor in patients with ulcerative colitis. The role of CMV in exacerbations of ulcerative colitis has been discussed. We believe that large controlled prospective trials are needed to clarify the benefit of antiviral therapy for active ulcerative colitis patients.